Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

74.14
-2.3700-3.10%
Pre-market: 75.000.8600+1.16%07:44 EDT
Volume:480.87K
Turnover:35.82M
Market Cap:2.85B
PE:-11.30
High:76.59
Open:75.89
Low:73.16
Close:76.51
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:1.00
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:4.42
PE(LYR):-12.33

Loading ...

Disc Medicine Chief Legal Officer Rahul Khara Disposes of 5,000 Common Shares for $400,000

Reuters
·
Aug 08

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Disc Medicine (IRON)

TIPRANKS
·
Aug 06

Press Release: Labrador IRON ORE Royalty Corporation - Results for the Second Quarter ENDED JUNE 30, 2026

Dow Jones
·
Aug 06

Analysts’ Top Healthcare Picks: Tvardi Therapeutics (TVRD), Disc Medicine (IRON)

TIPRANKS
·
Jul 31

Disc Medicine Publishes Corporate Presentation on Hematology Pipeline Targeting Heme, Iron Pathways

Reuters
·
Jul 30

Disc Medicine Posts Smaller-than-expected Q2 Net Loss

Reuters
·
Jul 30

Disc Medicine Q2 EPS $(1.54) Beats $(1.77) Estimate

Benzinga Earnings
·
Jul 30

Disc Medicine Q2 Net Loss Widens to $59.53 Million; R&D Expenses Rise to $46.93 Million

Reuters
·
Jul 30

Disc Medicine - Ends Q2 2026 with $717.70 Mln in Cash and Securities; Runway into 2029

THOMSON REUTERS
·
Jul 30

Disc Medicine Q2 Net Income USD -59.532 Million VS. Ibes Estimate USD -68.2 Million

THOMSON REUTERS
·
Jul 30

Disc Medicine Q2 Basic EPS USD -1.54 VS. Ibes Estimate USD -1.75

THOMSON REUTERS
·
Jul 30

Press Release: Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Jul 30

Press Release: Champion IRON Reports ITS Fy2027 FIRST Quarter Results

Dow Jones
·
Jul 30

Disc Medicine CEO John D. Quisel Disposes of Common Shares Worth $2.46 Million

Reuters
·
Jul 15

Disc Medicine COO Jonathan Yen-wen Yu Reports Sale of 100 Common Shares for $8,250

Reuters
·
Jul 10

Did Disc Medicine’s Expanded Hercules Credit Access Just Shift IRON’s Funding Risk Profile?

Simply Wall St.
·
Jul 01

Disc Medicine COO Jonathan Yu Disposes of 300 Common Shares Worth $21,750

Reuters
·
Jul 01

Disc Medicine - Enters First Amendment to Loan Agreement on June 25, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 01

Disc Medicine - to Draw Down $30 Mln of Tranche 1-B Advance - SEC Filing

THOMSON REUTERS
·
Jul 01

Disc Medicine Amends Hercules Loan Agreement, Draws Down $30 Million Tranche

Reuters
·
Jul 01